Autonomix Medical

Autonomix Medical, Inc. is a medical device company specializing in innovative technologies that revolutionize the diagnosis and treatment of peripheral nervous system diseases. Their groundbreaking platform utilizes a catheter-based microchip sensing array, boasting up to 3,000 times greater sensitivity than existing technologies, enabling transvascular diagnosis and treatment. Their initial focus is on alleviating pancreatic cancer and pancreatitis pain, which can be debilitating and currently lack effective solutions.

Autonomix's technology has the potential to address a wide range of indications, including cardiology, renal denervation, and chronic pain management. Their approach offers a more targeted and precise alternative to existing methods, potentially leading to improved patient outcomes and a better quality of life. Their commitment to innovation and a strong team with proven experience in the medical device industry position them as a leading player in the evolving field of electrophysiology.

Autonomix Medical is a medical device company dedicated to revolutionizing the diagnosis and treatment of diseases involving the peripheral nervous system. They strive to dramatically improve the quality of life for millions of people by empowering the nerve-targeted treatments of tomorrow. Their innovative technology platform utilizes a catheter-based microchip sensing array to detect and differentiate neural signals with high sensitivity, enabling precise diagnosis and treatment for conditions like pancreatic cancer pain, pancreatitis, and chronic pain management.

Autonomix Medical promotes a culture of innovation, collaboration, and patient focus. The company values groundbreaking technologies that can dramatically improve lives by empowering nerve-targeted treatments of tomorrow. This translates into a workplace where creativity is encouraged, teamwork is essential, and the ultimate goal is to bring hope and relief to patients suffering from a wide range of debilitating conditions.